Clinical Trial Update: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function [NA]

View source ↗

Summary

This clinical trial update reports an Abiomed-sponsored study evaluating Impella-supported PCI in high-risk patients with complex coronary artery disease and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure

Drugs mentioned

• Impella (Impella microaxial pump)

Snippet

Sponsor: Abiomed Inc. | Conditions: Left Ventricular Dysfunction, Coronary Artery Disease | NA | Status: ACTIVE_NOT_RECRUITING